Welcome
-
Home
-
Register
-
Login
-
Help/FAQ
-
0 items
Search
Enter keywords, a title or
a report id number below.
In All Categories
---------------------
Telecom & Computing
Business & Finance
Mfg & Construction
Pharma & Healthcare
Consumer & Retail
Gov & Public Sector
Energy & Transport
Country Reports
Company Reports
---------------------
Transcripts
Advanced
Select a currency for use throughout the site
Australia Dollars
Canada Dollars
Euro
Japan Yen
Sweden Kroner
Switzerland Francs
UK Pounds
US Dollars
Viewing report
Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
|
More
Electronic
Stakeholder Insight: Invasive Fungal Infections - Options Outweigh Replacements
Datamonitor, Jan 2004, Pages: 390
Description
Table of Contents
Enquire before Buying
Send to a Friend
Send to a Friend
To email a friend details of
Stakeholder Insight: Invasive Fungal Infections - Options Outweigh Replacements
complete the form below and click on "Send".
*
Required Information
Your Friend's Details
Friend's Full Name
*
Friend's Email Address
*
A message for your Friend
Your Contact Details
Your Name
*
Email Address
*
Customers who bought this item also bought
Strategic Perspectives: Invasive Fungal Infections - Cancidas and Vfend drive physician switching
Treatment Algorithms 2001: Venous Thromboembolism - Prophylaxis
Superficial Fungal Infections. Brand Awareness - the key to success?
Advances in the Treatment of Serious Systemic Fungal Infections--An Update
Pipeline Insight: Antithrombotics - Reaching The Untreated Prophylaxis Market
Pipeline Insight: HIV - Extending Treatment Options
Stakeholder Opinions: Nosocomial Infections - The Need for New Gram-negative Drugs
Diabetes: Opinion Leader Forum - Expert's Views and Perspectives on Diagnosis, Treatment, Product Performance, and Closing the Need Gap
Stakeholder Opinion: Atopic Dermatitis - A High Level of Unmet Need Creates Market Opportunities
Stakeholder Insight: Prostate Cancer - Hormone-Refractory Patients Still Waiting For Treatment Breakthroughs
Stakeholder Insight: Parkinsons Disease - Evidence of neuroprotection essential to progress treatment dynamics
Psoriasis - Biologics Impact Treatment Regimes Across The Globe
Top of page
All rights reserved. © Copyright 2009 Research and Markets
1
Terms and conditions
Privacy Policy
Publishers
Employment Opportunities
Site Map
Link to us
Webmaster